Denmark’s Regulator Suspends Drugmaker From Manufacturing

Drug Industry Daily
A A
The Danish Medicines Agency took action against a violative drugmaker by suspending its authorization to manufacture drugs and intermediates, following an inspection that revealed serious GMP violations.

To View This Article:

Login

Subscribe To Drug Industry Daily